GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Dex Liquidating Co (OTCPK:DXTRQ) » Definitions » YoY EBITDA Growth

Dex Liquidating Co (Dex Liquidating Co) YoY EBITDA Growth : 82.44% (As of Sep. 2017)


View and export this data going back to 2006. Start your Free Trial

What is Dex Liquidating Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Dex Liquidating Co's YoY EBITDA Growth for the quarter that ended in Sep. 2017 was 82.44%.

Dex Liquidating Co's EBITDA per Share for the three months ended in Sep. 2017 was $-0.07.


Dex Liquidating Co YoY EBITDA Growth Historical Data

The historical data trend for Dex Liquidating Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dex Liquidating Co YoY EBITDA Growth Chart

Dex Liquidating Co Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.71 27.35 23.96 16.64 11.84

Dex Liquidating Co Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.50 10.29 -56.15 72.81 82.44

Dex Liquidating Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Dex Liquidating Co's YoY EBITDA Growth for the fiscal year that ended in Jun. 2017 is calculated as:

YoY EBITDA Growth (A: Jun. 2017 )
=(EBITDA per Share (A: Jun. 2017 )-EBITDA per Share (A: Jun. 2016 ))/ | EBITDA per Share (A: Jun. 2016 ) |
=(-1.444--1.638)/ | -1.638 |
=11.84 %

Dex Liquidating Co's YoY EBITDA Growth for the quarter that ended in Sep. 2017 is calculated as:

YoY EBITDA Growth (Q: Sep. 2017 )
=(EBITDA per Share (Q: Sep. 2017 )-EBITDA per Share (Q: Sep. 2016 )) / | EBITDA per Share (Q: Sep. 2016 )) |
=(-0.072--0.41)/ | -0.41 |
=82.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dex Liquidating Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Dex Liquidating Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Dex Liquidating Co (Dex Liquidating Co) Business Description

Traded in Other Exchanges
N/A
Address
7 West 41st Avenue, Suite 245, San Mateo, CA, USA, 94403
Dex Liquidating Co currently has no business operations.
Executives
Younger William H Jr other: Former Director 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Newell Robert Y Iv officer: V.P., Finance, CFO, Secretary 2309 BERING DRIVE, SAN JOSE CA 95131
Liam Burns officer: VP,Worldwide Sales & Marketing C/O MODULAR MEDICAL, INC., 800 W. VALLEY PARKWAY, SUITE 203, ESCONDIDO CA 92025
Gregory D Casciaro director 361 RAQUEL LANE, LOS ALTOS CA 94022
Samuel E Navarro director C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044
Richard M Ferrari 10 percent owner, other: See Explanation of Responses 2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Broadfin Healthcare Master Fund Ltd 10 percent owner, other: See Explanation of Responses C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Broadfin Capital, Llc 10 percent owner, other: See Explanation of Responses 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Kevin Kotler 10 percent owner, other: See Explanation of Responses C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Gary S Petersmeyer director 3400 CENTRAL AVENUE, SANTA CLARA CA 95051
James C Gaither 10 percent owner 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Baker G Leonard Jr 10 percent owner 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304-1005
Tench Coxe 10 percent owner 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304
Pullara Samuel J Iii 10 percent owner 755 PAGE MILL ROAD, SUITE A-200, PALO ALTO CA 94304
Hill Ventures Sutter 10 percent owner 755 PAGE MILL RD, SUITE A200, PALO ALTO CA 94304

Dex Liquidating Co (Dex Liquidating Co) Headlines